ProfileGDS4718 / 222941_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 31% 24% 35% 29% 29% 37% 33% 25% 20% 26% 27% 26% 31% 34% 34% 26% 27% 44% 33% 27% 28% 29% 22% 28% 32% 37% 40% 41% 33% 26% 23% 29% 23% 33% 29% 35% 27% 26% 26% 50% 32% 26% 25% 32% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.6042731
GSM549102patient 115, normal, homogenized [OPG study]4.3273624
GSM549104patient 119, normal, homogenized [OPG study]4.7327235
GSM549108patient 138, normal, homogenized [OPG study]4.5445729
GSM549119patient 077, normal, homogenized [OPG study]4.492729
GSM549133patient 032, cancer, homogenized [OPG study]4.8099537
GSM549139patient 042, cancer, homogenized [OPG study]4.6642833
GSM549099patient 107, normal, homogenized [OPG study]4.3595125
GSM549109patient 139, normal, homogenized [OPG study]4.1681620
GSM549110patient 046, normal, homogenized [OPG study]4.3702626
GSM549114patient 063, normal, homogenized [OPG study]4.3789327
GSM549122patient 082, normal, homogenized [OPG study]4.3960526
GSM549134patient 033, cancer, homogenized [OPG study]4.5756231
GSM549136patient 036, cancer, homogenized [OPG study]4.6306734
GSM549140patient 044, cancer, homogenized [OPG study]4.6853134
GSM549111patient 047, normal, homogenized [OPG study]4.33726
GSM549113patient 057, normal, homogenized [OPG study]4.361527
GSM549132patient 031, cancer, homogenized [OPG study]5.1773144
GSM549137patient 038, cancer, homogenized [OPG study]4.6487733
GSM549142patient 047, cancer, homogenized [OPG study]4.5245327
GSM549100patient 110, normal, homogenized [OPG study]4.4744128
GSM549107patient 135, normal, homogenized [OPG study]4.477929
GSM549115patient 068, normal, homogenized [OPG study]4.1682122
GSM549116patient 072, normal, homogenized [OPG study]4.446128
GSM549120patient 078, normal, homogenized [OPG study]4.6059932
GSM549131patient 030, cancer, homogenized [OPG study]4.7729337
GSM549118patient 074, normal, homogenized [OPG study]4.9675440
GSM549129patient 027, cancer, homogenized [OPG study]5.0471341
GSM549123patient 088, normal, homogenized [OPG study]4.6399133
GSM549124patient 006, cancer, homogenized [OPG study]4.4198926
GSM549126patient 015, cancer, homogenized [OPG study]4.2495123
GSM549128patient 025, cancer, homogenized [OPG study]4.4763329
GSM549103patient 117, normal, homogenized [OPG study]4.3067223
GSM549117patient 073, normal, homogenized [OPG study]4.6352933
GSM549138patient 041, cancer, homogenized [OPG study]4.4764629
GSM549141patient 045, cancer, homogenized [OPG study]4.6746235
GSM549130patient 028, cancer, homogenized [OPG study]4.4224727
GSM549101patient 111, normal, homogenized [OPG study]4.3964226
GSM549105patient 128, normal, homogenized [OPG study]4.3966326
GSM549106patient 134, normal, homogenized [OPG study]5.4764750
GSM549112patient 048, normal, homogenized [OPG study]4.6241132
GSM549125patient 011, cancer, homogenized [OPG study]4.3981526
GSM549127patient 024, cancer, homogenized [OPG study]4.3262525
GSM549135patient 035, cancer, homogenized [OPG study]4.584832